GEHCV GE HEALTHCARE TECHNOLOGIES INC

GE HealthCare announces cash dividend for third quarter of 2024

CHICAGO--(BUSINESS WIRE)--

The Board of Directors of GE HealthCare Technologies Inc. (Nasdaq: GEHC) today declared a cash dividend of $0.03 per share of Common Stock for the third quarter of 2024 payable on November 15, 2024 to all shareholders of record as of October 18, 2024.

About GE HealthCare Technologies Inc.

GE HealthCare is a leading global medical technology, pharmaceutical diagnostics, and digital solutions innovator, dedicated to providing integrated solutions, services, and data analytics to make hospitals more efficient, clinicians more effective, therapies more precise, and patients healthier and happier. Serving patients and providers for more than 125 years, GE HealthCare is advancing personalized, connected, and compassionate care, while simplifying the patient’s journey across the care pathway. Together our Imaging, Ultrasound, Patient Care Solutions, and Pharmaceutical Diagnostics businesses help improve patient care from diagnosis, to therapy, to monitoring. We are a $19.6 billion business with approximately 51,000 colleagues working to create a world where healthcare has no limits.

Follow us on , , , , and for the latest news, or visit our website for more information.

EN
18/09/2024

Underlying

GEHCVGE HEALTHCARE TECHNOLOGIES INC

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on GE HEALTHCARE TECHNOLOGIES INC

EUR 229.85
GEHCV GE HEALTHCARE T...

GE HealthCare Technologies Inc.: Building a solid stand-alone track re...

Our credit view of this issuer reflects its strong base of stable, recurring revenues from services and consumables, offset by its competitive market environment.

GEHCV GE HEALTHCARE TECHNOLOGIES INC
6h / 31m 6h / 31m 1 EN
 PRESS RELEASE
Free
GEHCV GE HEALTHCARE T...

GE HealthCare reports third quarter 2024 financial results

CHICAGO--(BUSINESS WIRE)-- GE HealthCare (Nasdaq: GEHC) today reported financial results for the third quarter ended September 30, 2024. GE HealthCare President and CEO Peter Arduini said, “In the third quarter, we reported sales and orders growth of 1% globally. Both sales and orders grew in the mid-single digits excluding China, with particular strength in the U.S. across all segments. Pharmaceutical Diagnostics also delivered solid performance, driven by healthy procedure volumes. Ongoing lean initiatives across the organization are delivering better value to patients and customers and hav...

October 30, 2024 1 EN
GEHCV GE HEALTHCARE T...

Moody's Ratings announces completion of a periodic review of ratings o...

Moody's Ratings (Moody's) has completed a periodic review of the ratings of GE HealthCare Technologies Inc. and other ratings that are associated with this issuer. The review was conducted through a rating committee held on 23 October 2024 in which we reassessed the appropriateness of the ratings i...

GEHCV GE HEALTHCARE TECHNOLOGIES INC
10/29/24 October 29, 2024 1 EN
 PRESS RELEASE
Free
GEHCV GE HEALTHCARE T...

GE HealthCare announces CareIntellect for Oncology, harnessing AI to g...

CHICAGO--(BUSINESS WIRE)-- GE HealthCare (Nasdaq: GEHC) today announced CareIntellect for Oncology, a new cloud-first application that brings together multi-modal patient data from disparate systems into a single view, using generative AI to summarize clinical notes and reports. The application also surfaces relevant data allowing care teams to quickly understand disease progression and flag potential deviations from the treatment plan to help the clinician determine potential next steps and inform proactive interventions. The application, which is planned to be available to customers in U.S. ...

October 21, 2024 1 EN
 PRESS RELEASE
Free
GEHCV GE HEALTHCARE T...

GE HealthCare Announces AI Innovation Lab Showcasing Five New Research...

CHICAGO--(BUSINESS WIRE)-- GE HealthCare (Nasdaq: GEHC) today announced a new AI Innovation Lab, an initiative designed to accelerate early-concept AI innovations within the company. These projects are one part of GE HealthCare’s broader AI and digital strategy, which is focused on integrating AI into medical devices, building AI applications that enhance decision-making across the care journey and disease states, and using AI to support better outcomes and operational efficiencies system-wide. The company’s investment in cloud technology underpins this strategy, providing the computing power ...

October 21, 2024 1 EN

ResearchPool Subscriptions

Get the most out of your insights

Get in touch